e-learning
resources
Virtual 2021
06.09.2021
Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
A. Saikumar Jayalatha (Groningen , Netherlands), L. Hesse (Groningen , Netherlands), M. Ketelaar (Groningen , Netherlands), M. Van Den Berge (Groningen , Netherlands), V. Gurvey (Groningen , Netherlands), G. Koppelman (Groningen , Netherlands), M. Nawijn (Groningen , Netherlands)
Source:
Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Session:
Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Session type:
E-poster
Number:
2530
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Saikumar Jayalatha (Groningen , Netherlands), L. Hesse (Groningen , Netherlands), M. Ketelaar (Groningen , Netherlands), M. Van Den Berge (Groningen , Netherlands), V. Gurvey (Groningen , Netherlands), G. Koppelman (Groningen , Netherlands), M. Nawijn (Groningen , Netherlands). Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype. 2530
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Late Breaking Abstract - Transcriptional response to RSV in asthma primary bronchial epithelial cells: are the basal cells responsible for the reduced NF-kB response?
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Late Breaking Abstract: A role for IL-25 as ‘initiator‘ in Th2 driven inflammation is restricted to IL-5 high Th2 patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Late Breaking Abstract - GATA-3 in lung CD4+T cells drives Interleukin-10 deficiency-induced lung inflammation in asthma
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020
CD38 gene-modified dendritic cells inhibit murine asthma development through increasing IL-12 production and promoting Th1 cell differentiation
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001
Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012
IL-33 and TSLP gene expression are increased in response to human rhinovirus 1B in HDM-treated murine bone marrow-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Low number of regulatory T cells in bronchial asthma: association with inflammatory cytokines
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Association between T-regulatory cells blood content and Th2 cells activity in asthma
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model
Source: Eur Respir J 2005; 26: 1040-1046
Year: 2005
MiR-1165-3p downregulated in Th2 cells inhibits Th2 differentiation in allergic asthma by targeting PPM1A
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
Late Breaking Abstract - Bedaquiline enhances receptor phagocytosis and decreases IL1b production in human pro-inflammatory macrophages
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021
Activin-A is a critical inducer of human CD4+ICOS+IL-10-secreting regulatory T cells that suppress allergen-driven T cell responses in vitro and experimental asthma in a humanized mouse model in vivo
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
Normal T cell expressed and secreted (RANTES): a marker of asthmatic inflammation?
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004
Late Breaking Abstract - IL-33 drives influenza-induced exacerbations of asthma by halting anti-viral and Th1 responses
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept